Post by Stephan Hulsbergen

uniQure’s journey from academic spinout to global gene therapy leader showcases the power of platform innovation, strategic partnerships and regulatory expertise. Their milestones such as the first approved gene therapy in the West, market-defining commercial deals and breakthrough clinical data in hemophilia and Huntington’s offer valuable lessons for medtech entrepreneurs and investors on building lasting value in gene therapy. #genetherapy #huntingtonsdisease RegMed XB Smart BioMaterials Consortium (SBMC) BOM (Brabantse Ontwikkelings Maatschappij)